Calidi Biotherapeutics (CLDI) has shared an update.
David LaPre has stepped down from his role as a director of Calidi Biotherapeutics, Inc., including all board committee positions, effective immediately. His resignation is not due to any disagreements with the company’s operations, policies, or practices.
Find detailed analytics on CLDI stock on TipRanks’ Stock Analysis page.
